Real-world analysis of effectiveness in unresectable hepatocellular carcinoma patients treated with camrelizumab-based regimens.
Year: 2025
Type: article
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Yongxiang Xia, Xuehao Wang, Xiangcheng Li, Jia Luo, Bo Yuan, He Wang, Jinxue Zhou, Junzheng Wu, Hao Lu, Baina Zhang, SongNan Zhang, Chunxia Pan, Weifu Liu, Jianliang Wei, Sheng Gao, Linan Yin, Xiaojie Jiang, Sheng-Li Ma
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University, Central South University, Hunan Cancer Hospital, Xuzhou Central Hospital, Third Affiliated Hospital of Harbin Medical University, Zhengzhou University, Henan Cancer Hospital, People 's Liberation Army 451 Hospital, Xi'an Chest Hospital, Yanbian University Hospital, The Third People's Hospital of Dalian City, Fujian Provincial Cancer Hospital, Guidong People's Hospital of Guangxi Zhuang Autonomous Region, Zhejiang Shuren University, Putian University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410812383
